Kaya Ltd.

358.65 +3.95 ▲1.1%

22 February 2024, 04:01:00 PM
Volume: 483

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.kaya.in
Market Cap 468.35 Cr.
Enterprise Value(EV) 617.22 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -66.12 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 71.32 Trailing Twelve Months Ending 2023-12
Book Value / Share -104.70 Trailing Twelve Months Ending 2023-12
Price to Book Value -3.42 Calculated using Price: 358.50
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.31 Cr. 13,064,091 Shares
FaceValue 10
About Kaya Ltd.
The company offers various skin care services and beauty treatments. Today, Kaya Clinics successfully offer best skin and hair care solutions that enhance the look and feel of your skin and hair beautifully. All of this takes place in our state-of-the-art and ambient clinics. Plus, the services that they offer are designed and supervised by a team of experts that include trained dermatologists and beauty therapists. Kaya's experts have also put forward in-depth research to develop products from 13 distinct skin care ranges. It is their concrete formulations that add to the efficiency of the products in order to meet customers’ customized beauty needs.

Kaya Ltd. Delivery

Delivered Qty
Traded Qty

Kaya Ltd. Performance

1 Day
+1.11%
1 Week
-3.24%
1 Month
+9.23%
3 Month
+5.04%
6 Month
-5.01%
1 Year
+17.74%
2 Year
-5.08%
5 Year
-45.62%
10 Year

Kaya Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 20.9 3.76 -11.41 -8.68 -7.57 -46.11 -55.98 -263.21 0
Return on Capital Employed (%) 16.56 5.43 -9.62 -5.06 -4.65 -7.24 -18.27 -53.94 -121.62
Return on Assets (%) 8.99 2.24 -6.51 -4.87 -3.93 -14.21 -9.58 -18.64 -31.81

Kaya Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 235 251 229 210 158 82 54 -2 -104 -124
Non Curr. Liab. 15 18 5 2 10 142 131 166 224 211
Curr. Liab. 129 142 190 137 180 189 182 196 249 276
Minority Int. 0 2 2 1 1 0 1 1 0
Equity & Liab. 378 412 425 351 349 413 368 361 370 363
Non Curr. Assets 143 181 239 231 234 318 290 255 227 252
Curr. Assets 235 231 187 120 115 95 78 106 143 111
Misc. Exp. not W/O
Total Assets 378 412 425 351 349 413 368 361 370 363

Kaya Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 332 370 409 400 421 393 275 324 377 401
Other Income 15 12 11 10 4 9 15 12 5 7
Total Income 348 382 420 410 425 402 290 336 381 409
Total Expenditure -296 -352 -425 -398 -406 -338 -248 -297 -363 -389
PBIDT 52 30 -4 12 19 64 42 39 19 19
Interest -4 -4 -5 -7 -9 -22 -19 -21 -42 -43
Depreciation -12 -17 -20 -24 -29 -75 -60 -86 -93 -63
Taxation 3 0 6 -21
Exceptional Items -5
PAT 32 9 -27 -19 -14 -54 -37 -68 -116 -87
Minority Interest 0 -1 -1 0 0 -1 -1 0 0
Share Associate -1 -1 -2 0
Other Related Items
Consolidated Net Profit 32 9 -29 -21 -16 -54 -38 -69 -116 -86
Adjusted EPS 7 -22 -16 -12 -42 -29 -53 -89 -66

Kaya Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 92 29 5 -8 -12 22 47 32 30 63
Cash Fr. Inv. -11 -17 -6 -42 24 -28 -12 4 -35 -40
Cash Fr. Finan. -73 0 0 33 -7 5 -47 -31 12 -18
Net Change 7 13 -2 -16 6 -1 -12 5 7 5
Cash & Cash Eqvt 14 28 28 14 20 19 7 12 20 25

Kaya Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.93 59.93 59.93 59.93 59.93 59.93 59.93 59.93 59.93
Public 40.07 40.07 40.07 40.07 40.07 40.07 40.07 40.07 40.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kaya Ltd. Announcements

Thu, 15 Feb 2024
Grant Of ESOP
Intimation for Grant of ESOP
Tue, 30 Jan 2024
Board Meeting Outcome for Outcome Of Board Meeting - January 30 2024
Financial Results Q3FY24
Tue, 30 Jan 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Q3FY24

Kaya Ltd. Technical Scans

Thu, 22 Feb 2024
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
Closing Near 20 SMA Closing Near 20 SMA

Kaya Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,756.40 1,553.75 +0.7%
Cipla Ltd. 117,370.75 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. 106,155.83 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. 97,309.86 6,766.05 +0.1%
Divi's Laboratories Ltd. 96,809.75 3,642.80 -0.2%
Zydus Lifesciences Ltd. 91,584.23 904.80 +1.3%
Torrent Pharmaceuticals Ltd. 88,295.34 2,611.70 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.97 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 31.65 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.28 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 70.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.80 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,611.70 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 4.53 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.95 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.71 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,611.70 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,611.70 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,611.70 +0.4%

Kaya Ltd. FAQ's

What is Kaya share price?

Can I buy Kaya shares now?

What is the Market Cap of Kaya?

What is the 52 Week High and Low of Kaya?

What is the trend of Kaya share price?